|
Q4 2019
Filed on Feb 12, 2020
|
47,000
|
$28.77 - $46.1
$1.35M - $2.17M
|
|
First Finl Hldg CO Reg S Gdr
|
Q3 2019
Filed on Oct 29, 2019
|
101,900
|
N/A
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
88,681
|
$58.1 - $93.58
$5.15M - $8.3M
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
85,183
|
N/A
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
7,661
|
$33.01 - $33.68
$253K - $258K
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
1,451
|
N/A
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
2,155
|
$31.82 - $32.86
$68.6K - $70.8K
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
20,000
|
N/A
|
|
Cathay Financial 144 A Gdr
|
Q3 2019
Filed on Oct 29, 2019
|
169,211
|
N/A
|
|
Anworth Mortgage Asset Cp
|
Q3 2019
Filed on Oct 29, 2019
|
10,550
|
N/A
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
31,660
|
$6.08 - $7.89
$192K - $250K
|
|
Fi Enhanced Eur 50 Etn B Bcs
|
Q3 2019
Filed on Oct 29, 2019
|
35,947
|
N/A
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
271,847
|
N/A
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
56,969
|
$19.95 - $23.55
$1.14M - $1.34M
|
|
Aspen Pharmacare Hldgs LTD Adr
|
Q3 2019
Filed on Oct 29, 2019
|
22,449
|
N/A
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
105,726
|
N/A
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
323,762
|
N/A
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
119,448
|
N/A
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
70,000
|
$0.01 - $0.04
$700 - $2.8K
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
259,312
|
N/A
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
10,588
|
N/A
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
10,000
|
N/A
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
1,053,163
|
N/A
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
5,787
|
$35.36 - $38.45
$205K - $223K
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
5,181
|
$39.14 - $40.36
$203K - $209K
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
10,909
|
N/A
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
9,993
|
$30.19 - $31.16
$302K - $311K
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
10,000
|
N/A
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
2,000,000
|
N/A
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
14,943
|
N/A
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
3,606
|
$23.54 - $24.1
$84.9K - $86.9K
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
11,825
|
N/A
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
12,618
|
$8.12 - $14.54
$102K - $183K
|
|
Veloxis Pharmaceuticals A S
|
Q3 2019
Filed on Oct 29, 2019
|
15,000
|
N/A
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
4,639
|
N/A
|
|
|
Q3 2019
Filed on Oct 29, 2019
|
14,943
|
$11.37 - $14.79
$170K - $221K
|
|
|
Q2 2019
Filed on Jul 30, 2019
|
75,015
|
$42.02 - $52.62
$3.15M - $3.95M
|
|
|
Q2 2019
Filed on Jul 30, 2019
|
25,001
|
N/A
|
|
|
Q2 2019
Filed on Jul 30, 2019
|
7,177
|
$39.73 - $72.85
$285K - $523K
|
|
|
Q2 2019
Filed on Jul 30, 2019
|
7,745
|
$28.32 - $30.99
$219K - $240K
|
|
|
Q2 2019
Filed on Jul 30, 2019
|
14,577
|
$21.01 - $35.5
$306K - $517K
|
|
|
Q2 2019
Filed on Jul 30, 2019
|
11,256
|
$2.53 - $3.04
$28.5K - $34.2K
|
|
|
Q2 2019
Filed on Jul 30, 2019
|
12,035
|
N/A
|
|
|
Q2 2019
Filed on Jul 30, 2019
|
23,863
|
$14.73 - $17.45
$352K - $416K
|
|
|
Q2 2019
Filed on Jul 30, 2019
|
107,500
|
N/A
|
|
|
Q2 2019
Filed on Jul 30, 2019
|
7,798
|
$20.3 - $34.8
$158K - $271K
|
|
|
Q2 2019
Filed on Jul 30, 2019
|
29,345
|
$12.87 - $14.4
$378K - $423K
|
|
|
Q2 2019
Filed on Jul 30, 2019
|
154,065
|
N/A
|
|
|
Q2 2019
Filed on Jul 30, 2019
|
75,000
|
N/A
|
|
|
Q2 2019
Filed on Jul 30, 2019
|
15,702
|
N/A
|
|